• International Scientific Organization
    • Membership/APC
    • Contact us
  • International Journal of Chemical and Biochemical Sciences (IJCBS)
    • Instructions to authors
    • Editorial board
  • Volume 27 (2025)
    • Volume 27 (Issue 21)
  • Volume 26 (2024)
    • Volume 26 (Issue 20)
  • Volume 25 (2024)
    • Volume 25 (Issue 19)
    • Volume 25 (Issue 18)
    • Volume 25 (Issue 17)
    • Volume 25 (Issue 16)
    • Volume 25 (Issue 15)
    • Volume 25 (Issue 14)
    • Volume 25 (Issue 13)
  • Volume 24 (2023)
  • Volume 23 (2023)
  • Volume 22 (2022)
  • Volume 21 (2022)
  • Volume 20 (2021)
  • Volume 19 (2021)
  • Volume 18 (2020)
  • Volume 17 (2020)
  • Volume 16 (2019)
  • Volume 15 (2019)
  • Volume 10 (2016)
  • Volume 14 (2018)
  • Volume 13 (2018)
  • Volume 12 (2017)
  • Volume 11 (2017)
  • Volume 9 (2016)
  • Volume 8 (2015)
  • Volume 7 (2015)
  • Volume 6 (2014)
  • Volume 5 (2014)
  • Volume 4 (2013)
  • Volume 3 (2013)
  • Volume 2 (2012)
  • Volume 1 (2012)
  • Store
  • Cart
  • Account
International Scientific Organization International Scientific Organization
  • Please attach a menu to this menu location in Appearance > Menu.

International Journal of Chemical and Biochemical Sciences (ISSN 2226-9614)[/vc_column_text][/vc_column][/vc_row]

Start New Submission

 

 

 

VOLUME 26(20) (2024)

Investigating the Effects of Lithium and AKT Inhibitors on Insulin Resistance in a Rat Model

Areej Dawoud 1, Ahd Adel EL-Harbi1

1Ibn Sina National College for Medical Studies, Kingdom of Saudi Arabia- Jeddah

Abstract

                Insulin resistance, a fundamental aspect of metabolic diseases like type 2 diabetes and obesity, is defined by compromised insulin signaling and glucose absorption. This study sought to examine the impact of lithium, Protein Kinase B (PKB) or AKT inhibitors, and their combination on insulin resistance in a rat model generated by a high-fat diet (HFD). Fifty male albino rats were categorized into five groups: a control group, a high-fat diet (HFD) group, and three HFD treatment groups administered lithium, AKT inhibitors, or a combination thereof. Over a four-week period, we evaluated fasting insulin, blood glucose, HOMA-IR, liver function markers (Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST)), triglycerides (TG), inflammatory markers (Interleukin-1 beta (IL-1β), Tumor Necrosis Factor-alpha (TNF-α)), oxidative stress parameters (Malondialdehyde (MDA), Superoxide Dismutase (SOD), Glutathione Peroxidase (GPx), Catalase (CAT)), and gene expression associated with insulin signaling (insulin receptor (IR), Akt, glucose transporter type 4 (GLUT 4)). The findings indicated that both lithium and AKT inhibitors markedly enhanced metabolic, hepatic function, and inflammatory indicators. The AKT inhibitor alone was most efficacious in diminishing lipid peroxidation and inflammation, but the combined therapy offered the most comprehensive antioxidant protection. The data indicate that lithium and AKT inhibitors, either individually or in conjunction, may have therapeutic functions in the treatment of insulin resistance and metabolic diseases.

 

Keywords: Insulin resistance, Lithium, AKT inhibitor, High-fat diet, metabolic syndrome, Oxidative stress, Inflammation.

 

Full length article    *Corresponding Author, e-mail: areej-dawoud@ibnsina.edu.sa     Doi # https://doi.org/10.62877/20-IJCBS-24-26-20-20

 

International Scientific Organization- Atom to Universe

Journals

  • International Scientific Organization
    • Membership/APC
    • Contact us
  • International Journal of Chemical and Biochemical Sciences (IJCBS)
    • Instructions to authors
    • Editorial board
  • Volume 27 (2025)
    • Volume 27 (Issue 21)
  • Volume 26 (2024)
    • Volume 26 (Issue 20)
  • Volume 25 (2024)
    • Volume 25 (Issue 19)
    • Volume 25 (Issue 18)
    • Volume 25 (Issue 17)
    • Volume 25 (Issue 16)
    • Volume 25 (Issue 15)
    • Volume 25 (Issue 14)
    • Volume 25 (Issue 13)
  • Volume 24 (2023)
  • Volume 23 (2023)
  • Volume 22 (2022)
  • Volume 21 (2022)
  • Volume 20 (2021)
  • Volume 19 (2021)
  • Volume 18 (2020)
  • Volume 17 (2020)
  • Volume 16 (2019)
  • Volume 15 (2019)
  • Volume 10 (2016)
  • Volume 14 (2018)
  • Volume 13 (2018)
  • Volume 12 (2017)
  • Volume 11 (2017)
  • Volume 9 (2016)
  • Volume 8 (2015)
  • Volume 7 (2015)
  • Volume 6 (2014)
  • Volume 5 (2014)
  • Volume 4 (2013)
  • Volume 3 (2013)
  • Volume 2 (2012)
  • Volume 1 (2012)
  • Store
  • Cart
  • Account
INTERNATIONAL SCIENTIFIC ORGANIZATION- works with scientific research aim "atom to universe" Join us
Highend Church

©INTERNATIONAL SCIENTIFIC ORGANIZATION

  • International Scientific Organization
    • Membership/APC
    • Contact us
  • International Journal of Chemical and Biochemical Sciences (IJCBS)
    • Instructions to authors
    • Editorial board
  • Volume 27 (2025)
    • Volume 27 (Issue 21)
  • Volume 26 (2024)
    • Volume 26 (Issue 20)
  • Volume 25 (2024)
    • Volume 25 (Issue 19)
    • Volume 25 (Issue 18)
    • Volume 25 (Issue 17)
    • Volume 25 (Issue 16)
    • Volume 25 (Issue 15)
    • Volume 25 (Issue 14)
    • Volume 25 (Issue 13)
  • Volume 24 (2023)
  • Volume 23 (2023)
  • Volume 22 (2022)
  • Volume 21 (2022)
  • Volume 20 (2021)
  • Volume 19 (2021)
  • Volume 18 (2020)
  • Volume 17 (2020)
  • Volume 16 (2019)
  • Volume 15 (2019)
  • Volume 10 (2016)
  • Volume 14 (2018)
  • Volume 13 (2018)
  • Volume 12 (2017)
  • Volume 11 (2017)
  • Volume 9 (2016)
  • Volume 8 (2015)
  • Volume 7 (2015)
  • Volume 6 (2014)
  • Volume 5 (2014)
  • Volume 4 (2013)
  • Volume 3 (2013)
  • Volume 2 (2012)
  • Volume 1 (2012)
  • Store
  • Cart
  • Account